Equities research analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Fennec Pharmaceuticals in a ...

Q4 2024 Earnings Call Transcript March 10, 2025 Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year.

Reports Q4 revenue $7.93M, consensus $16.42M. “2024 marked the beginning of a foundational transformation for Fennec (FENC), setting the stage ...

FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$0.06 per share, missing estimates of $0.17 ...

Over-Year, and Generated PEDMARK ® Q4 2024 Net Product Sales of $7.9 Million ~ ~ Delivered Q4 2024 EBITDA Loss of $0.6 Million and Company Has $26.6 Million in Cash, Cash Equivalents and Short-Term ...

Analysts at HC Wainwright upped their Q1 2025 EPS estimates for Fennec Pharmaceuticals in a report issued on Tuesday, March ...

Good morning ladies and gentlemen, and welcome to Fennec Pharmaceuticals fourth quarter and full year 2024 earnings and corporate update conference call. (Operator Instructions) As a reminder, today's ...

Early Repayment of $13 Million of the Company’s Approximately $32 Million Outstanding Convertible Debt Facility: In December 2024, Fennec announced the early partial repayment of a significant ...

Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings and Corporate Update Conference Call. At this time, all participants are in a ...